Learning from Vioxx
14th Nov 2006, 10:00 GMT
THE RECALL in 2004 of Vioxx after the arthritis pain reliever was found to cause heart attacks and strokes is just one example of a drug that the Food and Drug Administration approved but then failed to monitor closely enough after it was on the market. Providing the agency with the resources and the authority needed to better ride herd ...
Learning from Vioxx related news:
- Mixed reviews for Vioxx successor — MSNBC.com: Health
- Merck: New pain drug safer than Vioxx — Financial news of the day - CNNMoney.com
- Merck: New drug safer than Vioxx — Business and financial news - CNNMoney.com
- Vioxx-Like Drug Gets Mixed Reviews — Dayton Daily News National Headlines
- Vioxx successor poses heart risk in study — Boston Globe -- Business News
- SyberWorks LMS e-Learning Implementation Podcasts: Episode #3 Interview with Melissa Phillips, TOUSA, Inc. — PR Leap - Software News Releases
- imc AG gründet Tochtergesellschaft in England — openPR.de Newsfeed : "IT, New Media & Software"
- Online Learning and Virtual Schools Provide Essential New Skills for 21st Century Jobs, Says Report — U.S. Newswire Releases
- Getting an advantage: Supply chain managers see advantages of certification — bizjournals.com High Tech:E-Commerce headlines
- Christian Distance Learning Degree Directory Exceeds 475 Entries — PR Leap - Religion News Releases
Latest news from Boston Globe -- Business News:
- What do pants and the space shuttle have in common?
- No-competition drugs stir controversy
- Like to chat at the movies? Lycos site may be just for you
- How many Easy Buttons have been sold?
- High Tech 25
- Life Sciences 25
- Deutsche Telekom CEO resigns
- Saudi stock slump leaves many mourning for lost paper profits
- Fledgling TV network creates Web-only lifestyle shows
- Sun makes Java code open source